Anthrax vaccine, BioThrax, receives Health Canada nod
by Press Release from Outbreak News Today on (#459N3)
Emergent BioSolutions Inc. today announced that Health Canada has approved the company's New Drug Submission (NDS) for its anthrax vaccine, BioThrax(R) (Anthrax Vaccine Adsorbed). BioThrax is indicated for active immunization for the prevention of disease caused by Bacillus anthracis, in individuals 18 through 65 years of age, whose occupation or other activities place them at risk of exposure, regardless ["]
The post Anthrax vaccine, BioThrax, receives Health Canada nod appeared first on Outbreak News Today.